The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Myc and the cell cycle
Abstract
Ectopic expression of the c-Myc oncoprotein prevents cell cycle arrest in response to growth-inhibitory signals, differentiation stimuli, or mitogen withdrawal. Moreover, Myc activation in quiescent cells is sufficient to induce cell cycle entry in the absence of growth factors. Thus, Myc transduces a potent mitogenic stimulus but, concomitantly, induces apoptosis in the absence of survival factors. We review here recent progress in our understanding of the molecular mechanisms linking Myc activity to cell cycle control. Myc is a positive regulator of G1-specific cyclin-dependent kinases (CDKs) and, in particular, of cyclin E/CDK2 complexes. Cyclin D/CDK4 and CDK6 may conceivably also be activated by Myc, but the circumstances in which this occurs remain to be explored. Myc acts via at least three distinct pathways which can enhance CDK function: (1) functional inactivation of the CDK inhibitor p27Kip1 and probably also of p21Cip1 and p57Kip2, (2) induction of the CDK-activating phosphatase Cdc25A and (3) - in an ill understood and most likely indirect way - deregulation of cyclin E expression. Constitutive expression of either Myc or cyclin E can prevent growth arrest by p16INK4a (an inhibitor of cyclin D/CDK4, but not of cyclin E/CDK2). In cells, p16INK4a inhibits phosphorylation, and thus induces activation of the Retinoblastoma-family proteins (pRb, p107 and p130). Surprisingly, this effect of p16 is not altered in the presence of Myc or cyclin E. Thus, Myc and cyclin E/CDK2 activity unlink activation of p16 and pRb from growth arrest. Finally, Myc may itself be a functional target of cyclin D/CDK4 through its direct interaction with p107. We discuss how the effects of Myc on cell cycle control may relate to its oncogenic activity, and in particular to its ability to cooperate with activated Ras oncoproteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
E2F: a nodal point in cell cycle regulation
Bernards, R. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00027-9 · Cited by 49
Functional Analysis of Burkitt's Lymphoma Mutant c-Myc Proteins
Smith‐Sørensen, B., Hijmans, E. M., Beijersbergen, R. L., & Bernards, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5513 · Cited by 45
Hurlin, P. J., Quéva, C., Koskinen, P. J., Steingrı́msson, E., Ayer, D. E., Copeland, N. G., Jenkins, N. A., & Eisenman, R. N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00555.x · Cited by 45
Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
Malkowicz, S. B., Tomaszewski, J. E., Aj, L., et al. (1996) · PubMed · Cited by 42
Haupt, Y., Harris, A. W., & Adams, J. M. (1992) · PubMed · Cited by 42
Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts.
Solomon, D. L., Philipp, A., Land, H., & Eilers, M. (1995) · PubMed · Cited by 41
The p130 pocket protein keeping order at cell cycle exit re-entrance transitions
Graña, X. (1998) · Frontiers in bioscience · doi:10.2741/a263 · Cited by 39
Hermeking, H., Wolf, D. A., Kohlhuber, F., Dickmanns, A., Billaud, M., Fanning, E., & Eick, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10412 · Cited by 39
Ittmann, M., Greco, A., & Basilico, C. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.10.3386 · Cited by 39
Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
Marhin, W. W., Hei, Y.-J., Chen, S., et al. (1996) · PubMed · Cited by 34
Ittmann, M., Ali, J., Greco, A., & Basilico, C. (1993) · PubMed · Cited by 29
Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H., et al. (1997) · The EMBO Journal · doi:10.1038/sj.emboj.7590578 · Cited by 5
Cited by
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Shaffer, A. L., Lin, K.-I., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,047
Metadata
- Authors
- Amati, B.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 1998
- Volume
- 3
- Issue
- 4
- Pages
- d250-268
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/a239
- OpenAlex
- W106241224
- Cited by
- 367
- References
- 212
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.